InvestorsHub Logo
Post# of 252252
Next 10
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: mcbio post# 148200

Wednesday, 09/05/2012 10:07:11 AM

Wednesday, September 05, 2012 10:07:11 AM

Post# of 252252
I find the fact that there are several compounds (peptide/nonpeptide antagonists, RNAi, or anti-CXCR4 mAb*) targeted to block the SDF-1/CXCR4 complex in clinical trials good for BLRX in the sense of validating the MOA.

http://www.ncbi.nlm.nih.gov/pubmed/22376154

* BMS-936564 isn't mentioned in the abs.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.